| Supplier |
Creative Peptides |
| Product # |
10-101-176 |
| CAS # |
275371-94-3 |
| Pricing |
Inquire
|
| LabelingTarget |
Glucagon-like peptide 1 (GLP-1) receptor
|
| Synonyms |
UNII-2PHK27IP3B
|
| MolecularFormula |
C152H232N40O45
|
| MolecularWeight |
3339.70948
|
| Source |
Synthetic
|
| Sequence |
H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Aib-Arg-NH2
|
| Storage |
-20°C
|
| Explanation |
Taspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche.
|
| Application |
Taspoglutide is developed for treatment of type 2 diabetes
|
| Activity |
Agonist
|
| AreasOfInterest |
Metabolic Disease
|
| Disease |
Type 2 diabetes
|